Purchase Order 75N95020P00128
Award Date 3/12/20
Potential Completion Date 3/11/22
Potential Value $15K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to the prime contractor Arc Trinova LIMITED, a for-profit manufacturer based in Great Britain, United Kingdom. The $15,725.17 firm fixed-price purchase order contract is for regulatory support, research and development, and compatibility testing services to support the continued development of the drug 2R,6R-HNK. This award is not associated...
- This firm-fixed-price purchase order, valued at $19,654.00, was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Arc Trinova LIMITED, a for-profit manufacturer, for compatibility testing to support the continued development of 2R,6R-HNK. The award does not have a set-aside designation. Arc Trinova LIMITED has previously received multiple prime contract awards and one subcontract award from federal agencies, including NIDA...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $30,316.20 firm fixed price purchase order to Horizon Discovery Biosciences Limited, located in Great Britain, United Kingdom. The contract is for unspecified products or services to be delivered between July 12, 2023 and July 22, 2023 in support of NIH's efforts to enhance the development, testing, and implementation of translational sciences. Horizon...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences has awarded Trilink Biotechnologies, LLC a firm fixed price purchase order valued at ten thousand two hundred fifteen dollars to purchase custom phosphorylated oligo synthesis. As a contract development and manufacturing organization, Trilink Biotechnologies specializes in providing modified nucleic acids and related products to support biomedical research. This award...
- The National Institutes of Health (NIH) awarded a $75,705.70 firm fixed-price purchase order contract to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, to provide PathHunter cell lines, reagents, and kits. The contract supports the Therapeutics for Rare and Neglected Diseases (TRND) program at the National Center for Advancing Translational Sciences (NCATS) within the NIH. The requested products will be used to develop dopamine D3 receptor antagonists for the...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Trilink Biotechnologies, LLC, a for-profit limited liability company. The contract, worth $3,880.27, is for the supply of specialized biotechnology products such as modified nucleic acids, reagents, and oligonucleotides. These materials are used to support biomedical research and diagnostic applications,...
- <p>The National Institute on Aging, a civilian federal agency, awarded a $22,000.00 Firm Fixed Price purchase order to Aristea Translational Medicine Corporation, a for-profit organization. The contract award, with no set-aside designation, is for translational medicine services. The contract has an ultimate completion date of September 18, 2018 and was awarded on July 20, 2018.</p>
- The federal contract award HHSN272201100404P was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Trionix Research Laboratory, Inc. on March 24, 2011. The $12,000 firm fixed-price purchase order contract has a completion date of September 30, 2011. The contract does not have a set-aside designation. Based on the award description of "TRIONIX (AMBIS #1547194)", this contract is likely for research and development services related to the AMBIS program, which...
- Curia Global Inc., doing business as Amri, has been awarded an $11,250 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to provide purification services for McHenry-CNA35 (4L). As a leading global contract development and manufacturing organization, Amri will utilize its expertise in medicinal chemistry, chemical development, analytical testing, formulation development, and cGMP...
- This is a task order award of $49,826.00 to Technical Resources International, Inc. (TRI) to provide regulatory support services for clinical trial testing of an influenza H10 stabilized stem vaccine under the National Institute of Allergy and Infectious Diseases (NIAID) Clinical Research Support Services 2017-2024 contract. TRI is a minority-owned, woman-owned, and Hispanic American-owned small business that specializes in providing comprehensive clinical research support services to federal...